| Scientific Name |
Nivolumab
|
|---|---|
| Brand Name |
Opdivo
|
| Risk |
Safety information about risk of Immune-related adverse reactions، Risk of Overlap Syndrome of (Myocarditis, Myositis, and Myasthenia Gravis)
|
| Educational Materials for Healthcare Professionals |
|
| Safety Communication for Healthcare Professionals |
|
| Educational Materials for Patients |
|